Skip to main content

Table 13 (abstract P13). See text for description

From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one

 

Before treatment

3th month of treatment

5th month of treatment

p*

HGB

12,11 ± 1,16 (12,08)

12,20 ± 1,03 (12,05)

12,38 ± 1,02 (12,31)

0,027*

HCT

38,05 ± 3,19 (38,02)

38,63 ± 3,45 (38,30)

38,82 ± 2,81 (38,27)

0,135

PLT

350.932 ± 110.096 (334.600)

310.671 ± 85.475 (309.850)

303.202 ± 81.570 (296.700)

<0,001*

SAA

192,19 ± 295,14 (38,95)

20,26 ± 46,58 (3,85)

9,68 ± 25,81 (3,30)

<0,001*

IRON

53,47 ± 29,56 (50,85)

66,76 ± 35,61 (56,50)

67,41 ± 31,15 (64,00)

<0,001*

TIBC

361,09 ± 52,93 (362,50)

364,78 ± 55,12 (365,00)

372,91 ± 48,92 (366,00)

0,163

FERRITIN

56,63 ± 42,46 (45,00)

34,69 ± 21,34 (30,55)

32,74 ± 23,80 (25,55)

0,002*